Get all your news in one place.

100’s of premium titles.
One app.

Get all your news in one place.

100’s of premium titles. One news app.

The Latest Breaking News from the Food and Drug Administration

FDA approves first OTC birth control pill - Roll Call

The Food and Drug Administration on Thursday approved Opill, making it the nation’s first over-the-counter birth control pill.

Roll Call

The FDA is being asked to look into Logan Paul’s energy drink, which has the caffeine of 6 Coke cans

The influencer-backed energy drink Prime is popular among children but lawmakers and health experts are concerned over its potentially dangerous levels of caffeine.

Chicago Sun-Times

Miracle new Alzheimer's drug which slows cognitive decline of disease to be rolled out

The Food and Drug Administration (FDA) has approved the much awaited drug Leqembi which has been shown to slow the cognitive decline caused by Alzheimer’s, the most common type of dementia

Daily Mirror

From analysis to the latest developments in health,
read the most diverse news in one place.

Alzheimer's drug Leqembi gets full FDA approval. Medicare coverage will likely follow

The first drug found to slow the progression of Alzheimer's disease has been granted full approval by the Food and Drug Administration.

WEKU

Regeneron Stock Crumbles After FDA Rejects Its Next Blockbuster Contender

The Food and Drug Administration rejected a high-dose version of Regeneron's eye drug Eylea on Tuesday, leading REGN stock to crumble.

Investors Business Daily

5 takeaways from the AP's report on Chinese disposable e-cigarettes flooding the US market

The Associated Press has found that the Food and Drug Administration can't keep up with a flood of illegal disposable e-cigarettes from China

The Independent UK

Moderna Stock Rises After FDA Application For Updated Vaccine

Moderna's potential beyond COVID-19 is underappreciated, says analyst Eliana Merle, who upgraded the stock to Buy

Zenger

Read news from The Economist, FT, and more,
with one subscription

An Alzheimer's drug is on the way, but getting it may still be tough. Here's why

The Food and Drug Administration is expected to grant full approval to the Alzheimer's drug lecanemab by July 6. But access to the drug may still be limited.

WEKU

FDA warns stores to stop selling Elf Bar, the top disposable e-cigarette in the U.S.

The warning from the Food and Drug Administration is the latest attempt by regulators to crack down on illegal disposable vapes that have poured into U.S. stores in recent years.

WEKU

Are masks for the birds? We field reader queries about this new stage of the pandemic

The official emergency is over but COVID is still here. And that means ... lots of questions. We asked our readers what's on their mind and then called on experts for advice.

WEKU

FDA advisers back updated COVID shots for fall vaccinations

A panel of advisers to the Food and Drug Administration has recommended revising the current COVID-19 vaccine so that it specifically targets omicron.

WEKU

FDA advisers endorse new RSV antibody drug for babies

A panel of experts to the Food and Drug Administration has recommended the agency approve a long-acting antibody drug that can protect infants from the seasonal virus, RSV.

WEKU

Biohaven, A Top 2% Stock, Exits 'Stealth Mode' And Hits A Record High

Biohaven is coming "out of stealth mode," an analyst said Thursday as BHVN stock climbed for a fourth consecutive day.

Investors Business Daily

Commentary: By avoiding funding Alzheimer’s research, the government is cutting seniors’ life spans

Millions of patients and their caregivers breathed a collective sigh of relief when drugmaker Eli Lilly recently announced its new experimental Alzheimer’s medication appears to slow cognitive decline by 35%. The Food and Drug Administration could approve the new treatment, donanemab, as soon as this year.

Chicago Tribune

Get all your
news in one place.

100’s of premium titles.
One news app.

Tribune News Service

The FDA approved a new drug for hot flashes. Here's why it shows 'a lot of promise'

The Food and Drug Administration last Friday approved fezolinetant, or Veozah, to treat hot flashes for women in menopause. The non-hormonal drug treatment is the first of its class and represents an option for women who cannot take hormones.

WEKU

FDA advisers support approval of RSV vaccine to protect infants

At least 58,000 childern younger than 5 years old are hospitalized each year with RSV infections. A Pfizer vaccine given to pregnant people could help protect their infants from severe RSV illness.

Reason

Doctors Detail Dangerous Pregnancy Care in States With Abortion Restrictions

Plus: APA says social media not inherently harmful for kids, senators propose Artificial Intelligence Regulatory Agency, and more...

The Independent UK

New menopause drug for hot flashes gets FDA approval

The Food and Drug Administration has approved a new type of drug to treat hot flashes caused by menopause

Get all your
news in one place.

100’s of premium titles.
One news app.

Reason

CNN Gave Trump a Megaphone and He Used It Exactly as You'd Expect

Plus: American conservatives are becoming more European, FDA approves birth control "mini pill" for over-the-counter sale, and more...

WEKU

Advisers to the FDA back first over-the-counter birth control pill

In a unanimous vote, 17-0, a panel of advisers to the Food and Drug Administration recommended that the agency approve the first over-the-counter birth control pill.

WEKU

The FDA considers first birth control pill without a prescription

The Food and Drug Administration is weighing whether to allow a birth control pill to be sold over the counter for the first time. An advisory committee opens a two-day hearing Tuesday.

LiveScience

Don't use 'amniotic fluid' eye drops, FDA warns

"Amniotic fluid" eye drops aren't approved and could be harmful, the Food and Drug Administration warned.

WEKU

Here's what really happened during the abortion drug's approval 23 years ago

A Texas judge ruled that the Food and Drug Administration wrongly approved mifepristone in 2000 and accused it of doing a rush job. Here's what really went down.

Tribune News Service

Commentary: Abortion pill ruling means more painful, later terminations

The conservative 5th Circuit has blocked part of a Texas judge’s decision to pull abortion drug mifepristone off the market, but leaves in place onerous and outdated restrictions that the Food and Drug Administration determined in 2016 were medically unnecessary.

St. Louis Post-Dispatch

Editorial: Judge had a basis for his attack on FDA, but not regarding mifepristone

The chiefs of more than 400 pharmaceutical companies signed a scathing letter this week blasting federal Judge Matthew Kacsmaryk’s ruling that the Food and Drug Administration had overstepped its authority in approving the abortion-inducing drug mifepristone. The letter was more than justified and, while harshly worded, accurately recounted Kacsmaryk’s abysmal…

1 … 5 6 7 8

People

Chiquita BrooksLaSure

From analysis to the latest developments in health,
read the most diverse news in one place.

Organisations

the World Health Organization

514 stories

CMS

418 stories

Food and Drug Administration

the Food and Drug Administration

196 stories

MRNA

191 stories

Read news from The Economist, FT, and more,
with one subscription

Topics

Artificial Intelligence

Places

Fourteen days free

Download the app

One app. One membership.
100+ trusted global sources.